These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8202329)
41. CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors. Indinnimeo M; Reale MG; Cicchini C; Stazi A; Fiori E; Izzo P Int Surg; 1997; 82(3):275-9. PubMed ID: 9372374 [TBL] [Abstract][Full Text] [Related]
42. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer. Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404 [TBL] [Abstract][Full Text] [Related]
43. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Ebert W; Muley T; Drings P Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537 [TBL] [Abstract][Full Text] [Related]
44. A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients. Schneider J; Bitterlich N; Kotschy-Lang N; Raab W; Woitowitz HJ Anticancer Res; 2007; 27(4A):1869-77. PubMed ID: 17649786 [TBL] [Abstract][Full Text] [Related]
45. [Trials of the diagnostic potentials of TPA in tumorous and nontumorous lung pathologies in 303 cases]. Aquilina R; Bergero F; Magri G; Noceti P; Mirabelli S Minerva Med; 1992; 83(7-8):415-9. PubMed ID: 1522964 [TBL] [Abstract][Full Text] [Related]
46. [Lung cancer]. Komagata H; Yoneda S Gan To Kagaku Ryoho; 2004 Oct; 31(10):1609-13. PubMed ID: 15508459 [TBL] [Abstract][Full Text] [Related]
47. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery]. Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670 [TBL] [Abstract][Full Text] [Related]
48. [Interleukin 3 (IL-3) in diagnosis and monitoring of non-small-cell lung cancer]. Mroczko B; Szmitkowski M; Czygier M Przegl Lek; 1999; 56(12):763-6. PubMed ID: 10789186 [TBL] [Abstract][Full Text] [Related]
49. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
50. [Relation between the level of TPS, NSE, CEA and beta2-mG in the serum and the biological behavior of small cell lung cancer]. Chen MS; Xu Y; Ma J; Wu CG; Hao XK; Lu BB; Liu T Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug; 23(8):751-3. PubMed ID: 17618570 [TBL] [Abstract][Full Text] [Related]
51. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer]. Yang J; Li R; Li A Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234 [TBL] [Abstract][Full Text] [Related]
52. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [TBL] [Abstract][Full Text] [Related]
53. [Dimorphous cancer of the lung]. Briusov PG; Leonova VV Vopr Onkol; 1997; 43(2):205-7. PubMed ID: 9214124 [TBL] [Abstract][Full Text] [Related]
54. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer]. Fujii M; Kiura K; Kamei H; Segawa Y Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270 [No Abstract] [Full Text] [Related]
55. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Nisman B; Amir G; Lafair J; Heching N; Lyass O; Peretz T; Barak V Anticancer Res; 1999; 19(4C):3549-52. PubMed ID: 10629651 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer. Wu GP; Ba J; Zhao YJ; Wang EH Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156 [No Abstract] [Full Text] [Related]
57. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835 [TBL] [Abstract][Full Text] [Related]
58. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098 [TBL] [Abstract][Full Text] [Related]
59. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung]. Zeng L Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022 [TBL] [Abstract][Full Text] [Related]